Loading…
← CockpitCompetitor Analysis › HTFL HeartFlow, Inc.Open in the cockpit ↗

HeartFlow, Inc.HTFLCompetitor analysis, valuation and peers

United States · USD·Information Technology›Packaged Software

Makes an AI software that analyzes coronary CT scans to non-invasively assess heart blood-flow blockages.

Momentum leader 85
Mkt cap
$4.03B
US dollars, full cap
Free float
75%
of shares outstanding
$/day
$99.1M
20-day average traded
Fwd P/E
n/m
no positive forecast
ROIC−WACC
-57.6 pp
WACC 17.5%
Hurdle
n/a
no reverse DCF
Next earnings
126 days
24 Mar 2027
Close · USD$45.89
1D-2.5%
1W-22.4%
1M-17.4%
3M-1.9%
6M+67.6%
YTD+57.4%
1Y+73.8%
ATR %8.0%
Beta1.88
52w lowhigh24.3% off high

What HeartFlow does

Makes an AI software that analyzes coronary CT scans to non-invasively assess heart blood-flow blockages.

Paid per case: a hospital sends a patient's heart CT scan to HeartFlow's cloud service and receives a 3D model of blood flow, then seeks payment from Medicare and private insurers. Sales therefore depend on cardiologists ordering CT scans before invasive procedures and on what insurers pay for the analysis.

Products and services

  • HeartFlow FFR-CT analysis software
  • Plaque/coronary artery disease analysis

Customers

  • Hospitals/cardiology practices
  • Radiologists/cardiologists

Where it sits in the supply chain

  • Information technology
  • Healthcare/medical imaging AI
  • Non-invasive cardiac diagnostic…

What could go right

  • Growing adoption as alternative to invasive angiography
  • Expanding insurance/Medicare reimbursement

What could go wrong

  • Reimbursement/payer coverage risk
  • Competition from imaging OEMs' own AI tools

Moat: narrow (IP / patents, regulatory licence, data). FDA-cleared, clinically validated AI algorithm with a growing base of reimbursed clinical evidence.

Headquarters: Redwood City, California, United States · Founded: 2007 · Employees: 843

Named competitors

HeartFlow at a glance

Size HeartFlow (HTFL) is a United States Information Technology company (Packaged Software) with a market value of $4.03B, the 1334th largest of 3,085 United States companies the cockpit tracks. Shares closed at $45.89 on 18 Nov 2026.

Performance Over six months the shares gained 67.6%, against -2.4% for the median peer and -2.2% for the United States market (cap-weighted) — 4th highest of 20 in its peer set.

Growth Revenue grew 39.9% over the last twelve months (peer median +19.2%); the operating margin is -30.0% (peer median 11.8%).

Valuation It trades at 16.3× enterprise value to sales against a peer median of 5.4× (3rd most expensive of 21).

Capital Return on invested capital runs 57.6 points below its cost of capital (17.5% WACC).

Short interest Short interest is 6.5% of the free float (30 Oct 2026).

Next results Next results expected around 24 Mar 2027 (exchange calendar; dates can move).

Relative performance

10015020021 May 202621 Aug 202618 Nov 2026HTFL 157Peer median 98
Six months, rebased to 100: HeartFlow against the median of its 20 peers (local-currency closes).

HeartFlow financials

Reported figures in USD; fiscal year ends 2025-12-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023
Revenue$239M$176M$126M$87.2M
Revenue growth—+40%+44%—
Gross profit$195M$135M$94.4M$58.1M
EBITDA-$62.1M-$55.5M-$53.1M-$65.3M
Net income-$79.0M-$117M-$96.4M-$95.7M
Free cash flow-$56.1M-$59.0M-$73.4M-$82.5M
Capital expenditure$7.11M$5.03M$4.36M$6.11M
Total debt$25.9M$22.1M$160M$161M

Quarterly statements and history in the cockpit →

HeartFlow competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

0%+100%+200%-20%0%+20%+40%HUBMGNI60053638883635OPLNAPPN002195VIAKXS688411MAASSRAD301396PLFADLO6460HTFL6-month return →1-month return →
Up and to the right = strong over both horizons. HeartFlow is the large dot.

Fundamentals: revenue growth against valuation

-20%0%+20%+40%0×10×20×30×LFTOHUBMGNI60053638883635OPLNAPPN002195VIA688411MAASSRAD600588301396PLDLOHTFLRevenue growth (TTM) →EV / Sales →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. HeartFlow is the large dot.

HeartFlow competitors and peer comparison

Head to head with its named competitors (HTFL vs SHL.DE vs GEHC vs AYA.AX)
CompanyMarket cap6M returnRevenue growthOp. marginEV / SalesReq g
HeartFlow HTFL$4.03B+68%+40%-30%16.3×n/a
Siemens Healthineers SHL.DE$53.7B+27%+1%14%2.6×9.6%
GE HealthCare GEHC$37.8B+30%+7%14%2.1×5.0%
Artrya AYA.AX$285M-43%0%-97,479%12,568.9×n/a

How HeartFlow compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

HeartFlow against its 20 peers (data as of 18 Nov 2026)
MeasureHTFLPeer medianRank in peer set
1-month return-17.4%+1.2%2nd lowest of 21
6-month return+67.6%-2.4%4th highest of 20
Distance from 52-week high-24.3%-25.1%11th highest of 21
Revenue growth (TTM)+39.9%+19.2%4th highest of 21
Operating margin-30.0%11.8%lowest of 20
EV / Sales16.3×5.4×3rd most expensive of 21
ROIC minus cost of capital-57.6 pp-2.0 pplowest of 19

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginEV / SalesReq gDelivered g
HeartFlow HTFLUnited States$4.03B+68%+40%-30%16.3×n/an/a
Liftoff Mobile LFTOUnited States$4.07Bn/a+35%40%5.9×-7.2%+35.2%
HUB24 HUB.AXAustralia$3.98B-12%+23%29%11.9×34.2%+35.7%
Magnite MGNIUnited States$3.98B+112%+9%18%5.2×28.5%+26.4%
China National Software & Service 600536.SSChina$3.97B-28%-16%0%5.9×48.5%-7.3%
Kingsoft 3888.HKHong Kong$3.97B+5%0%14%0.9×-11.0%+10.8%
Koei Tecmo 3635.TJapan$4.10B+27%+19%43%5.5×-4.4%+7.9%
OPENLANE OPLNUnited States$4.18B-2%+13%17%3.1×11.4%-2.4%
Appian APPNUnited States$3.86B+153%+22%5%4.8×34.9%+19.0%
Shanghai Stonehill Technology 002195.SZChina$4.25B-40%+11%-25%30.5×n/an/a
Via Transportation VIAUnited States$3.83B+221%+29%-17%6.7×n/an/a
Kinaxis KXS.TOCanada$4.27B+54%+18%18%6.6×13.8%+20.6%
Beijing HyperStrong Technology 688411.SSChina$3.81B-34%+38%12%2.0×n/an/a
Maase MAASUnited States$4.29B-5%-84%-13%160.6×n/an/a
Sportradar SRADUnited States$3.76B-10%+25%13%2.1×9.2%+25.8%
Yonyou Network Technology 600588.SSChina$4.34B-25%+4%-16%3.5×n/an/a
Glory View Technology 301396.SZChina$3.72B-50%+53%n/a12.7×n/an/a
Planet Labs PBC PLUnited States$4.38B-72%+44%-26%10.6×n/an/a
First Advantage FAUnited States$3.70B+41%+18%12%3.2×18.7%+25.3%
DLocal DLOUnited States$3.69B+8%+57%18%2.1×1.2%+60.0%
Sega Sammy 6460.TJapan$4.43B+54%+19%10%1.4×-2.1%+11.9%

Questions

Who are HeartFlow's main competitors?
Named competitors: Cleerly (private or unlisted), Siemens Healthineers (SHL.DE), GE HealthCare (GEHC), Artrya (AYA.AX). The cockpit's measured peer set (industry) also includes Liftoff Mobile (LFTO), HUB24 (HUB.AX), Magnite (MGNI), China National Software & Service (600536.SS), Kingsoft (3888.HK), Koei Tecmo (3635.T).
Is HeartFlow expensive compared with its peers?
On ev / sales it trades at 16.3× against a peer median of 5.4×, 3rd most expensive of 21 in its peer set.
How has HeartFlow stock performed?
Over six months to 18 Nov 2026 the shares returned +67.6% against -2.4% for the median peer; over one year +73.8%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.